Back to Results
First PageMeta Content
Pharmacology / Clinical pharmacology / Therapeutics / United States Public Health Service / New Drug Application / FDA Fast Track Development Program / Mifepristone / Prescription Drug User Fee Act / Nancy Fern Olivieri / Food and Drug Administration / Pharmaceutical sciences / Medicine


United States Government Accountability Office GAO Report to Congressional Requesters
Add to Reading List

Document Date: 2008-08-18 11:13:09

Open Document

File Size: 710,06 KB

Share Result on Facebook

City

Washington / DC / /

Company

Danco Laboratories L.L.C. / /

Country

France / United States / /

/

Event

FDA Phase / M&A / /

Facility

American College of Obstetricians / /

IndustryTerm

mifepristone product / manufacturing deficiencies / email communications / study protocols / manufacturing / drug products / /

MedicalCondition

severe infection / illness / infections / deficiency syndrome / severe bacterial infection / HIV/AIDS / /

Organization

Mifeprex United States Government Accountability Office Washington / FOOD AND DRUG ADMINISTRATION / Honorable Michael B. Enzi Ranking Member Committee on Health / U.S. government / American Association of Pro Life Obstetricians and Gynecologists / Centers for Disease Control and Prevention / United States Senate / Population Council / US Federal Reserve / the American College / Department of Health and Human Services / Honorable Roscoe G. Bartlett House of Representatives In / /

Person

Marcia Crosse / /

/

Position

Governor / representative / /

Product

Subpart H / Letairis / Subpart H. This / Mifeprex / FDA / /

ProgrammingLanguage

DC / /

Technology

study protocols / /

URL

http /

SocialTag